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The cellular distribution of mRNAs for urokinasetype plasminogen activator (uPA), its specific receptor (uPAR), and its inhibitors (PAI-l and -2) in mouse skin was analyzed by in sitlt hybridization after topical application of the tumor promoter phorboI12-myristate 13-acetate. In the epidermis, strong signals for uPA and PAI-l mRNA were detected 24 h after treatment in the basal and suprabasal epidermal keratinocytes in areas with pronounced hyperproliferation and increased terminal differentiation, and in some hair follicle keratinocytes. After 48 h, both uPAR and PAI-2 mRNAs were expressed in the epidermal layers from the suprabasal keratinocytes up to the differentiating cells beneath the cornified layer and in hair follicle keratinocytes. Induction of P AI-2 mRNA was detected in epidermis as early as 3 h after treatrnent and remained stable for up to 7 days. In the dermis, 5 h after application of phorbol 12-myristate 13-acetate to the skin, uP A mRNA was detected in fibroblast-like cells below and around the skin muscle, and PAI-l mRNA was detected in stromal cells I nvasion of cancer cell s requires degradation of the extracellular matl;x. Of the several proteolytic enzymes involved in this process (Dan0 e/ ai, 1985; Mignatti and R.ifkin, 1993) , the serine prote inase urokina se-~y pe pla s minog~n activator (uPA) and members of th e matrL">: m etalloprotemase fumtly are the best studied . uPA plays an important role in a numbe r of physiologic conditions in which degradation of the extracellular matrix is req uired for tissue re modeling and cell migration, e.g., wound healing, in vo lu tion of the mammary gland, trophob last implantatio n, and inva sion of ca n cer cell s (Dan0 el ai, 1985; Mignatti and Rifkin, 1993) . The tempora l and spatial enzymatic Manuscript received September 8, 1995; revised November 29, 1995: accepted for publi cation December · 1, 1995.
R eprint requests to: Leif R. Lund. Finscn Laboratory, n . . . igshospitalet, Strandboulevardcn 49, 2100 Cope nh agen 0. Denmark . Abbreviation s: uPA, urokinase-type plasminogen activator; PAl. plasmi nogen activator inhibitor; uPAR. urokinase-type plasminogen activator receptor; PMA , "horbol 12-myristate 13-acetate; PBS. phosphate-buffered sa lin e ; R... T -peR., reverse t ran scription-po lYl11crasc c hain reaction. located above the skin muscle. After longer exposure to phorbol 12-myristate 13-acetate, the PAI-l mRNAexpressing stromal cells were located more superficially, apparently moving toward the epidermal layer. After 9 h, most of the PAI-l mRNA-positive cells were identified as endothelial cells. Up to 24 h after the application of phorbol 12-myristate 13acetate, the intensity of the signal for both uPA and PAI-l increased, followed by a gradual decrease for up to 7 days. These results show that in mouse skin treated with a tumor-promoting phorbol ester, the various components of the plasminogen activation system are expressed by both epithelial and stromal cell types, which in dermis and subcutis are located in different places, depending on the time of exposure to the phorbol ester. Our results suggest that urokinase-rnediated extracellular proteolysis has diverse functional roles during the early steps of tumor promotion. Key words: plasllli1logell actilmtionlclrell,.ical cQrci-1wgctlesislplwl'bol IIIY"ista tc aceta leIs lm III a l-epU/lei iaJilltel 'actiolls. ] Invest Dennatol 106:622-630, 1996 actIvI ty of uPA is ,·egulatcd by two specific inhibi to rs, PAI-1 and PAI-2. both belonging to the serpin class of inhibitors (Andreasen et ai, 1.990), and by a specific cell-sur£1 ce rece ptor. uPAR (Vass:llli cl ai, 1985) . uPAR is a cysteine-rich , highly glycosylated protein attached to the celJ surface by a phosphatidylinositol g lycolipid anchor (Behrendt c/ ai, 1990; Plollg ef ai, 1991; Solberg e/ ai, 1992) . Complete human and mouse uPAR cD NA s h ave been isolated (Roldan el ai, 1990; Kristensen el al. 1991 a) . lIPAR binds both active uPA and its virtua ll y inactive proenzyme form. pro-uPA , with high a ffinity . Pro-uPA ca n be activated to uPA by plasmin w illie bound to uPAR, and rece ptor-bound uPA in turn activates plasminogen (Blasi el ai, 1987) . Concomitant bindin g of pro-uPA and plasmirlOgen to the cell surC,c e acce le rates phlSlninogen activation (Ellis 1:/ al. 1.991.) . making the cell surface the prefe rential site for the urokinase pathway of plasminogen activatio n [for reviews see Ellis and ])an0 (1991) and Dan0 el ai, (1994) ]. Thus, regulation of the lJPA system becomes complex when it is considered that, under physiologic conditions, its variolls compon ents are expressed not necessarily b)i the same cells but often by various types of neighboring cells (Dan0 c/ (II, 1994) .
It is likely that cytoki n es playa c ru cia l role in the regulati o n of the uPA syste m , b oth in tiss u e remodeling during n o rma l physiologic events and during cancer in vas ion. A lthough t h e e ffects of hormones, cytokines, and t um o r pro m ote rs o n the expression of va r io u s compo n e nts of the PA syste m ha ve been studi ed in detail ill v itro [fo r reviews see A ndreasen ct ai , (1990) , Saksela a nd Rifkin (1988 ), a nd Laiho and Keski-O j" (1989)], o nl y a few studi es h ave bee n d evoted to th e ir effects ill /li/lo (Quax et ai , 1990 ; Sawd ey a nd Los kutoff,1991).
Mouse skin h as been used extensiv e ly as a n ill /li/lo model system for e lu c idatin g the tumor-promoting r o le of PMA durin g c h e mi cal carcinoge n esis. Top ica l app li catio n of a sin g le dose of PMA o n mo u se skin eli cits a stro n g pleiotropic respo n se in t h e e pide rmis a nd derm is, including in c reased proliferatio n of the basa l keratinocytes , fo llowed by a h y p e rpla stic response a nd inflamma tion and a n increased rate of terminal dilfe re nti ation of t h e keratinocytes (Potten, 198 1 ; Slaga. 1983; Reiners a nd S laga, 1983; Yuspa and P o il'ier, 1988) . Indu ctio n of the express io n of Va l'iOU S gen es by PMA trea tment, including transforming g rowth facto r-{31 mRNA and protein (Akhurst el. ai, 1988; Fowlis Cf ai, 1992;  K r ieg c f ai, 1991.), interleu k.in-l a (Oberyszyn et ai, 1993 ) , c-Jos a nd C-IIIJ1C (Rose-John et ai, 1988), str o l11 e lysin-1 (Ostrowski ct ai, 1988; Wright ef ai , 1994), a nd osteopontin (Craig et ai, 1989) , as well as d efects in the regul ation of dilfere nti ation and proliferation in initiated keratinocytes, are co n side re d key eve nts in ea rl y tumor d evelopmen t of the epidermis [Yu spa and Poirier (1988) ; for rev iew, see Bowden and Krieg (1991) ]' The effect of PMA on ge n e expression ha s also b ee n stu di e d intens ive ly in cell c ulture syste m s, where it was ea rly shown to increase plasminogen acti vato r activity in H e La cell s (Wigle I' and Weinstein, 1976) . Later it was shown that PMA also indu ces mRNA a nd protein fo r PAI-1 (Lund el ai, 1988; Mayer et ai , 19 88), uPA (Stoppe lli et ai, 1986) , and uPAR (Lund et ai, 1 991 b , 1995;  Picon e el ai, 1989) in so m e but n ot all teste d cell lines, su ggesti n g a cell-specific res p o n se to PMA t reatm e nt.
By immunohistoch e mi cal an alys is and ill silll h ybridization , we have previously sh o wn that PAI-l and uPA mRNA and protein are differ e ntiall y a nd specifi call y induced in the basal a nd su pra b asa l ke r a tillocytes, res p ective ly, durin g re-e pitbelia li za tion of mouse skin wo unds (Gnmda hl-Ha ns en et al. 1988 ; R.e m e r et ai, 1991), w hereas uPAR is ex p ressed b y the lea din g edge of keratinocytes (Remer et ai, 1994) . T h ese o bservation s suggest a tightly regulated expression of th e vario us compone nts of the pl asm ill ogen activation sys tem in m o u se skill durin g ti ss u e remod e li n g, infl a mmati o n , and cell migration b y unknown factors . Bec ause ill ,)ilro studi es do n ot always re fl ec t the situation ill II;'J() , we h ave extende d our previo u s ill ,Jil/'o studi es of the regulatory e ffects of PMA o n ex pression of the vario u s co mp o n e n ts of the P A syste m . H e re we re port the sh ortterm elfects of topi cal appli cation of PMA to m o u se skin on t h e express ion of uP A, uPAR, PAI-l, a nd PA I-2 mRN A as d etected by i'l sitll h ybridizatio n.
MATERJALS AN D METHODS
Materials PMA and PMA 4-0 -mcthyl ether were obtain ed fro m Sigma Chem ica l Co. (St. Lo uis, MO) T7. T3, and SP6 polymerase, DNase I. a random priming DNA kit, dithiothreitol, restri ction end onucleases. and a monoclonal antibody directed agai nst a macrophage-specifi c anti gen (Mac-1) we re obta ined fi:o m Boehrin ger (Mannheim , German y). All other materials we re desc ribed previo usly (Kristenscn ef nl , 199 ' 1 a, b; Lund c/ nl , 1991a, 1995; R..e me r ('I nl, 199 1, 1994) .
Animal and Tissue Treatluent Procedures. T he mi ce used wcre 8to 1 O-week-o ld femalc BALB/ c (Fibi ger In stitute, Cope nhagen Denmark), kept in animal ho usin g filc ili ties at 25 ::' :: 2°C, 55 ::' :: 5% humidity with an artificial day-night rhythm of 12 h eac h. and fed sta ndard food pellets (Altrom in number ' 1 314. o btained fro m hI'. Petersen , Rin gsted, Denmark) and water nd libillllll . T he ba cks of the mi ce were sha ved the day befo re the onset of the experiments. which all started at 9 a. m. pMA (6 .25 ILg) was ap plied topica ll y in 200 ILl of acetonc and covered the shaved area completely (approx im ate ly 3 cm 2 ) . Contro l mice were un treated o r treated w ith solvent (200 ILl ofacctone) alo ne. T he mi ce used for RNA preparation or protein extraction were anesthetized with die th),lcther iml11 ediately be fore usc and perfused in tr;Jca rdially with 20 1111 of icc-cold phosphate-buff'ered sa lin c (PBS) . T he dorsa l skin wa s rcmoved and immediately frozen in an ethanol/dl) ' icc bath o r in liquid nitrogen and then stored at -80°C un ti l RNA purifi catio n o r extractio n of prote ins. Skin fronl t\vo rnicc in each group was used.
Mice used for ill situ hybrid izatio n or inl l11Ull ohi stochcll,jca l analysis \vere treated w ith PMA for pe ri ods of 3 h to 7 days (at lea st two mice per treatment gro up) o r with PMA 4-0-methyl ether for 24 or 72 h. Control mi ce were untreated or treated w ith so lvent alone. T he mice were treated as described abovc. excep t that after perfusion with ice-cold PBS they were intraca rdi all y perfused with 20 ml of 4% (w i v) parafonnalde hyde in PBS.
T he treated sIGn \vas rc rn ovcd and cu t into slices. T hese spcc inlc lls ' , vere post-fixed fo r 16 h in 4% parafonnald ehyde in PBS and processed for paraffin e mbeddin g. All experiments were performed according to protocols approved by the Danish Anima l Research Co mmi ttee.
Preparation of RNA Probes T he fo ll ow ing fi'agm ents of mo use uPA cDNA (Belin c' nl, 1985) , mo use PAI-1 cDNA (Pre ndergast and Cole. 1989), mou se PAI-2 cDNA (Belin ef nl, 1989) , and mouse uPAR cD NA (Krisrcnsen CI nl, 1991 a) were subcloned: for uPA , pMUPA07 fragment (608-1642) in pGEMS z, or pMUPA09 fragme nt (37-428) in pB luescript KS( + ) (Kristensen et nl, 1991b) ; for PAl-I. pl11PAl102 fragment (6-338) o r pmPA I1 03 fi'agment (338-857) in pBIu escript KS ( + ); for PAI-2, pmPA I21 fragme nt (188-453) or pmPAI22 fi'agment (6 16-931) in pBlu escript KS ( + ); for uPAR , p5 0A/1 P-X fragment (151-362) or p50A12XB fragment (362-461) in pBluescript KS ( + ). T he last two plasmids are fi'agments of mouse upAR cDNA covering sequences that are identica l iUl110use u pARl and uPAR2 (Kristensen cl nl, 1991 a) . e SSjUTP antisense or sense probes wc re gene rated by transcription of the plasm ids with the relevant polymerase (SP6, T3 , orT7) as described previously (Kristensen el nl. 1991b ). Probe concentratio n was always more than 2 X 10(' c pm l ILl , alld the activity of the two corresponding RNA probes transcribed from the oppos ite strand of the same plasmid was adj usted to the same radioactivity concentration . Labeled probes were stored at -20°C until usc.
I" Sit" Hybridization 111 Silll hybridization was performed as described in derail previously (Pyke "I nl, 1994) . BrieRy, 5-ILm para/tin-e mbedded sections of the skin on chrome-alun gelatin-coated or Superfros t+ slid es were deparafrini zcd in " . . y lene and treated with proteinase K. After hybridization ove m ight with the labe led RNA probe, the section s were washed. treated with RNase A and RNase T I • de hydrated, and air-dried . Autoradiographi c ellluision was app li ed, and sections were developed after J 0 days of exposure.
RNA Isolation and Analysis Tota l RNA was purified by the me thod of C ho mczYlISki and Sacchi (19 87) . Poly(A) + RNA was o bta in ed by purificatio ll on po ly(dT) columns as described pre viously (Re mer ('( nl. 199 1). Specific III RN A was detected by reverse transcription-po lymerase chain reaction (RT-PC R). Pol y(A) + R..NA (50 ng) was reverse-transcribed ill 20 ILl of reverse trallScl;ptase buffe r, co ntaining 10 ILM random hexadeoxyn ucleotides, IOU of R.nasin . and 10 U of avian myel o bla sros is virus reverse transcriptasc for 45 mill at ·n oc. T hese cD NA preparations were di lu ted 10-fold, and 1 O-ILI aliqu ots were add ed to the PCR reactions: PCR buff' er ( 10 mM Tris/ H C I. pH 9.0.50 mM KCI, 2.0 mM MgC I 2 ), 0.00 1';;', (w l v) gela ti n, 0.0 1% (v l v) Triton X 100. 200 ILM concentration of each deo,, ),nucleotide. 25 pmol of cach primer. and 1 U ofTaq pol ymera se in a tota l vo lul1l e of 100 ILl. PCR ampli fication proceeded for 30 cycles: 94°C fo r 45 s. 55°C (uPAR primers) o r 45°C (uPA and PAI-l primers) for 45 s, 72°C fo r 45 s. T he PC R primers for murine uPAR.: nu cleotid es 392-410 and 714-735 (Kristensen el nl. 199 'l a); for uPA: nucleotides 404-427 and 1,00 1-1 ,024 (Be lin el nl. ' 1 985); fo r PAl-I: lIu cleotides 512-528 and 992-1 .008 (Prendergast and o le. 1989): for PAI-2: nu cleotides 490 -5 11 and 782-802 (Belin el nl, 1989) ; and for {3-actin: nu cleotides 25-44 and 246-270 (A lolISo ," nl, 1986) . The PCR products were subseq uently electroblotted onto a GeneScree n nylol1 mcmbran e afrer agaros" gel electro ph oresis and denaturation. Polynucleotides we re cross-Ii li ked to the membrane by UV ti ght and hyb6di zed wi th '5S-labeled IIPAR, uPA , PA l-I. PAI -2 , or {3-actin cDNA probes in a hybridi zation so lution as described previo usly (So lberg cf nl , 1992) .
R ES ULTS
Histologic Changes of the Mouse Skin After a Single Treat-Inent with PMA T h e first v isible morpho logic c h a n ges that followed a sin g le topical ap pli cation of the tumor promote r PMA to t h e b acks ofBALB/c mi ce were marked e l) ,t h e ma and e dem a of t he affected areas of t h e skin . Within dl e first 3-5 b after treatment, there was a dramatic influx of inA amJ11 ato ry cells, mainly n e utrophils, to the subc utis and lower dermis be low the trea ted area (Fig  lB) , whereas mi ce treated with solvent alo n e h ad n o suc h rea c tion (a and b) and PAI-l mRN A (c and d) in the epide rmal keratinocytes . T he ti ssuc sectio ns arc viewed with cither light-tie ld (a and c) o r dark-field (b and d) microsco py. Note that the signa ls for uPA and PAI-l mRN A arc res tricted to the basal and so mc suprabasa l kcratinocytes . Sca le bar, 10 p.m. (Fig lA) . T h e m aximal influx of infiammacoI), cell s to t h e d e mlis was seen 16 to 24 h after treatment (Fig lC) . Infl a mm atory cells wer e also d e tec ted in the ep idermi s, interspe rsed a mong the differentiated k e ratinocytes (data not shown). Up to 72 h after PMA treatme n t, the numbe r of infl a mm atory cell s gra du all y d ecreased (Fig lD) , a nd after 7 days th e numbe r of inflammatory cells was comparable to t h at seen in the solve n t-treated contro l mi ce. As judged by m o rph o logic crite ria, ini tiation of cell divisio n in basal epid erma l keratinocytes and onset of term ina l differentia tion were obviolls within the first 24 h a fte r PMA trea tm e nt (Fig lC) , a nd after 72 h the epid e rmis con sisted of seve ra l la yers of k eratinocytes, including a b asa l laye r and four to six la ye rs of diffe rentiating supra basa l cell s (Fig lD) . There was n o d etecta ble e ffect of the non-tumor-promoting phorbol este r PMA 4-0-meth yl eth er after 24 or 7 2 h (data n ot sh ow n ).
uPA, uPAR, PAl-l, and PAl-2 mRNA Expression in Mouse Skin Exposed to PMA, as Detected by ill Sit" Hybridization Epiderlllis Twenty-four b ours afte r the application of a single dose of PMA, a strong sig nal for PAI-l mRNA was d etected in basal keratinoc ytes b e low areas w ith h yperprolife ration and in c reased te nnin a! diffe re ntiatio n. Forty-eight h ours after PMA treatment, uPA mRN A was also present in basal and so m e suprahasa l differe ntiating keratinocytes as we ll as ill som e h air fo llicl e keratino cytes (Fig 2, a-d) . Both uPA and PAI-l In R.N A exp ression wa s still d etected in the k e ratin ocytes for up to 7 days (data n ot shown) . c and d) . The sectio ns are viewed by ught-field (a and c) or dark-field (b and d) mi croscopy. Note that botb uPAR and PAI-2 mR.NA arc expressed by the suprabasaJ kera tinocytcs and by the differentiating ce ll s ben eath the co rnified layer. Sca le bar, 10 JLm.
Forty-eight bours after exposure to PMA, uPAR mRNA expression was de tected in epidermal keratinocytes and in some hair foUicle keratinocytes. The highest expression in epid ermis was seen in the layers of differentiating cells above the basal keratinocytes and beneath the comified layer (Fig 3, a and iI) . At later times the intensity of the signaJ for uPAR mRNA decreased.
After only 3 h of PM A treatment, a very strong signal for PAI-2 mRNA was detected in the differentiating keratinocytes above the basal layer and in hair follicles . After 48 h the signal for PAI-2 mRNA was confined to the supra basal layer and the layers of keratinizing cells beneath the cornified layer: (Fig 3, c and tf) , and it remained highly expressed for up to 7 days (data not shown).
The signals for uPA, uPAR, PAl-I, or PAl-2 mRNA were below detections limits for in sitll hybridi zation in the epidermis of untreated mice, mice treated with non-tumor-promoting phorbol esters, or mice treated with solvent alone (data not sh own).
Derlllis nlld SlIliCIIlis Expression of uPA and PAI-l mRNA was induced in cells located in the dermis and subcutis a few hours after application of PM A to the dorsal skin. Five hours after exposure to PMA, uPA mRNA was present in distinctive fibroblast-like cells located below and between the muscle cells of the musculus panniculus (Fig 4, a and iI) . At the same time, PAI-l mR.NA was seen in stroma'! cells located above the ski n muscle (Fig 4, c and tf) .
Nine hours after exposure to PMA, there was a marked i.ncrease in the intensiry ofPAI-l ml~NA expression in individual cells and an increase in the overall number of positive cells. Most of the cells expressing PAI-l mR.NA were accumulating in the upp er dermal layer and co uld be identified as endothelia l cells (Fig 4, e and J) , whereas the rest of these cells remained unidentified . Staining of adjacent sections with a macrophage marker (a-Ma c-I IgG) reveal ed that the cells positive for uPA and PAI-l mRNA were not macrophages (data not shown). Between 24 hand 7 days after exposure to PMA, there was a gradual decrease in the intensity of both the PAI-l and uPA mRNA signals in the dermis. In general, more pronounced effects on uPA and PAl-l mRNA expression were obtaiJled when a higher dose of PMA was used, but it then resulted in toxic side effects such as pronollnced edema, necrosis, and partial separation of the epidermis from the de rmis (data not shown). No uPAR or PAI-2 mRNA was detected in dermis or subcutis lip to 7 days after application of PMA.
No hybridization signals for uPA or PAl-l mRNA were detected in the dennis of untreated mice or mice treated with solvent alone (data not shown).
Control ExperiUlents The specifi city of the signals for each of the mRNAs was supported by virtually identical results obtained with antisense RNA from two different, nonoverlapping cDNA VOL. 106, NO. . ...
!.
EXPRESS ION OF uPA , uPAR. PAl-I, AND PAI-2 mRN A 627 Figure 4 . uPA and PAI-l mRNA expression in stronlal cells in mouse skin 5 h after PMA treatment. [II silll hybridization for uPA mRNA (a and b) and PAI-l mRNA (c and rI) in adjacent sections of mouse skin afte r treatment with PMA for 5 h and for PAI-l mRNA (<' and) after treatment with PMA for 9 h. The sections are viewed by light-field (a, c, and e) or dark-field (b, d, and .I) microscopy. Note the localization of uPA mRNA in fibroblast-like cell s below or between the ski n muscle (an'OI"s in a and b), whereas PAI-l mRNA was seen in stromal cells more superficiall y located above the ski n mu scle (c aud rI). After 9 h of PM A treatment, the number of PAl-I-expressing cell s had increased and they were located in the upp er part of the dem1is (e and 1; ano"'s clones. The corresponding sense RNA probes were used as negative controls, and all showed no specific hybridization signal (data not shown).
uPA, uPAR, PAI-l, and PAI-2 mRNA in Mouse Skin Extracts Total RNA was extracted from normal, full-thickness mouse skin and from mouse skin treated with a single dose of PM A for 5, 24, or 48 h. Poly(A) + RNA was isolated and analyzed by RT-PCR analysis with uPA-, uPAR-, PAl-l-, and PAI-2-specific primers as described in Materials arlll Methods. The PCR products were separated by agal'ose gel electrophoresis and analyzed by Southern blotting with uPA, uPAR, PAl-I , and PAI-2 cDNA probes, Although this very sensitive method is only semiquantitative, it showed a strong induction of uPA and PAI-2 mRNA after the PMA treatment. As shown in Fig SA, a low mRNA was detected in normal ski.n, and a strong increase was observed after 5, 24, and 48 h of PMA treatment. uPAR mRNA was de tected both in untreated mouse skin and in PM A-treated skin; however, only the uPAR 1 form was detected ( Fig SB) , A modest increase of PAI-1 mRN A was observed after PMA treatment (Fig sq, and a very strong increase of PAI-2 mRNA was observed ( Fig SD) . Hybridization signals with simihll' intensity were observed in all samples when {3-actin-specific primers were used in the PCR (Fig SE) , showing that the rnRNA from the skin extracts was intact.
DISCUSSION
We have demonstrated that mRNAs for all the components oftlle uPA-catalyzed plasminogen activation pathway are induced, in a potent, fast, and widespread manner, in the pleiotropic response of mouse skin to a single topical application of the tumor promoter PMA. 330th the spatial and temporal expression patterns differed for each component, suggesting div erse functional roles of urokinasecatalyzed proteolysis in the skin jn respons e to PMA treatment. 1\1 the epidermis, induction ofPAI-2 mRNA was detected remarkably early, at only 3 h after application of PMA, whereas uPA , uPAR, and PAI-l mRNA expression was detected somewhat later. The strongest signals for uPA and PAI-l mRNA were seen in the basal layer of keratinocytes, in contrast to the pattern of expression for uPAR and PAI-2 mRNAs, which were seen in the more superficial cell layers of epidernlis. The functional role of the urokinase system in the keratinocyte response to PMA treatment remains to be resolved, but it is possible that urokinase-m ediated proteolysis i involv e d in the accelerated continuous shedding of the corn.ified layers of epidermis by release of the interceHular desmosomal connections between keratinized celis. In view of our previous findings of uPA, uPAR, and PAI-1 expression in the migrating keratinocytes during re-epith elialization of mouse skin wounds (R0!11er et III, 1991, ] 994) and of uPA (Sappino e/ al, 1991; Miller et ai, 1992) and uPAR O. R0m er, unpublished observation) in the invading cancer cells of squamous skin carcinomas, a picture i emergillg that extracellular proteolysis generated by receptor-bOllnd uPA at the cell surface is implicated in the migration of keratilJOcytes and squamoLls cancer cells. Tllis would take place by release of cell-cell and cell-substrate contacts, whether the cells are moving into a wound, infiltrating the surroundings of a skin carcinoma, or shedding from the superfIcial cornifIed layer of PMA-treated e pidermis. In a recent study it was found that the matrix m etalloproteinase strOl11.elysin-l was induced ill a subset of dermal fibroblasts and in some basal keratinocytes within 6 h of PMA treatment and with maximal effect at 16-20 h, suggesting that the elfect on stromelysin-l expression is more transient than the effect on the various components of the plasminogen activation system (Wright et al 1994) . The different time course of induction and localization of the strol11elysin-1-positive fibroblast-like cells in the upper dermal compartment makes it h.ighly unlikely that tbe same cells are positive for uPA or PAI-l and stromelysin-l and suggests that they have different induction pathways and functional roles. There is a shift in expression of stromelysin-l from stromal cells to cancer cells during the conversion from squamous to spindle carcinomas during chemical skin tumor progression (Wright cl aI, 1994) . Future experiments are required to confirm that there is a similar shift in expression of the various components of the urokinasecatalyzed plasminogen activation system during skin tumor progression .
The early induction and widespread expression of uP A and PAl-l but not llPAR and PAI-2 were also seen in the dermis and subcutis. uPA and PAI-l mRNA was detected in stromal cells in dennis and subcutis 5 h after application ofPMA. uPA mRNA was detected in fibroblast-like cells. The cells positive for PAf-l mRNA were seen to move toward the upper part of the dermis at later times, when many of the cells were identified as endothelial cells. The fa st induction of uPA and PAl-l l11RNA was not restricted to the mRNAs; an inc rease in both uPA an d PAI-l prote in levels was detecte d b y direct and reve rse fibrin zym ogrnph y, resp ectivel y (data n ot shown). T h e fast induction of uPA and PAI-l in th e dennis is co mparabl e to that of ea rl y response gen es, but th e func tional signifi ca n ce o f thi s observation re mains to b e es tablish e d.
T he locali z atio n o f PAI-2 mRN A to the keratini z ing cell layers of PMA-treate d e pide rmis and to th e sup erfi cial la ye rs of psol'iatic epidermal keratin ocytes (Lyons-G io rd ano cl ai, 1994) m ay b e related to th e de mon stration of PAI-2 as a substrate for the tiss u e-type transg lutamin ase in tropho bl asts Oensen Cl ai, 1993) and to a n in creased ke ratinocyte-spe cifi c tran sgllltaminase activi ty in PMA-treate d m o u se skin (G up ta cl ai, 1989; Fuc h s, 1990) . T his makes it tempti n g to spec ul ate that PA 1-2 might be a sub strate for the k e rarinocyte-specific transglutam in ase and , as su ch , m ay playa role in th e fo rm ation of the insoluble cross-linked m e mbran e envelope (Thach er and R.i ce, 1985) fou nd in th e cornified cells.
T h e rapid inductio n of both uPA and PAT-l mRNA in th e dermis and ofPA I-2 mR.NA in th e suprab asa l ke ratino cytes su ggests tha t it is a primary e ffect of PMA o n transcriptio n of th e resp ective gen es. All three ge n es h ave bee n show n to respond rapidl y to PMA trea tm ent ;11 ,,;11'0 (Stoppelli el ai, 1986; Sc hl e llnin g et ai, 1987; Maye r el ai, 1988). T he slowe r induction of uP A, lIPAR, an d PAl-l rnl~A in th e epidermis mig ht sugges t that thi s expressio n is due to a seco ndary efFect ofP M A. It has been sh own by oth e rs that a single application of tumor-promotin g phorbol esters to m o u se skin ind u ces th e expression of several ea rl y and seco ndary respon se genes and ge nes fo r growth f.,cto rs and cytoki n es in the epidermis (Holl aday el ai , 1992). T ransformin g grow th factor-J31 h as b ee n show n to regu late uPA, uPAR, aJld PAI-l mRNA synth es is ;11 ,,;11' 0 [Keski-Oja el al (1988) , L und cl al (1987, 1991 a) ; for reviews see An dreasen el al (1990) and Laiho and Kcski-Oja (1 989)] . It is an attrac tiv e h ypoth es is that th e indu ction of the uPA system is ca used by o n e o r m ore of th e cyto kincs synth es ized in thc m o u sc skin. Appli catio n of nc utrali zin g antib odies to se lected cyto kin e s co uld provide dire ct evidence of wh e the r such m o lecular m ech ani sm s playa fun cti o nal rol e in th e pl e iotropic res ponses of PM A-trea te d skin .
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